EMFAT
IMGN

Emerald Mutual Fund Advisers Trust’s Immunogen Inc IMGN Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,188,209
Closed -$35.2M – 261
2023
Q4 		$35.2M Sell
1,188,209
-277,854
-19% -$5.53M 1.87% 5
2023
Q3 		$23.3M Buy
1,466,063
+649,069
+79% +$10.8M 1.4% 15
2023
Q2 		$15.4M Buy
+816,994
New +$9.65M 0.84% 55

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's IMGN Position: Q1 2024 in Review

Emerald Mutual Fund Advisers Trust sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 1,188,209 shares — an estimated $35.2M sold.

Emerald Mutual Fund Advisers Trust first reported a position in IMGN in Q2 2023 and held it in 3 quarters. The position peaked at $35.2M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Emerald Mutual Fund Advisers Trust reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 1,188,209 Immunogen Inc shares in Q1 2024, an estimated $35.2M.
  • Emerald Mutual Fund Advisers Trust first reported a position in Immunogen Inc in Q2 2023 and held it in 3 quarters.
  • Emerald Mutual Fund Advisers Trust's Immunogen Inc position peaked at $35.2M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q1 2024, filed 8 May 2024.